Advanced company searchLink opens in new window

CENTUS BIOTHERAPEUTICS LIMITED

Company number 09679603

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
16 Jan 2018 PSC09 Withdrawal of a person with significant control statement on 16 January 2018
13 Nov 2017 AP01 Appointment of Yoshifumi Torii as a director on 30 September 2017
19 Oct 2017 TM01 Termination of appointment of Hideaki Nomura as a director on 30 September 2017
21 Jul 2017 CS01 Confirmation statement made on 8 July 2017 with updates
20 Jul 2017 SH01 Statement of capital following an allotment of shares on 20 April 2017
  • USD 120,000,000
20 Jul 2017 SH01 Statement of capital following an allotment of shares on 20 December 2016
  • USD 110,000,000
20 Jul 2017 SH01 Statement of capital following an allotment of shares on 22 August 2016
  • USD 98,000,000
18 Apr 2017 AA Accounts for a small company made up to 31 December 2016
11 Apr 2017 AP01 Appointment of Karl David Bradshaw as a director on 13 March 2017
13 Mar 2017 TM01 Termination of appointment of John Trainer as a director on 13 March 2017
21 Jul 2016 AP01 Appointment of Mr Mitsuhiro Sato as a director on 22 June 2016
20 Jul 2016 CS01 Confirmation statement made on 8 July 2016 with updates
01 Jul 2016 TM01 Termination of appointment of Seimi Satake as a director on 22 June 2016
06 Jun 2016 AP01 Appointment of John Trainer as a director on 2 May 2016
16 May 2016 TM01 Termination of appointment of Michael Craig Diem as a director on 2 May 2016
26 Apr 2016 AD01 Registered office address changed from 2 Kingdom Street London W2 6BD to 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge England and Wales CB2 0AA on 26 April 2016
21 Dec 2015 SH10 Particulars of variation of rights attached to shares
21 Dec 2015 SH08 Change of share class name or designation
21 Dec 2015 SH01 Statement of capital following an allotment of shares on 1 December 2015
  • USD 90,000,000
21 Dec 2015 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Appoint new dir company business 01/12/2015
15 Dec 2015 AP01 Appointment of Hideaki Nomura as a director on 1 December 2015
15 Dec 2015 AP01 Appointment of Seimi Satake as a director on 1 December 2015
07 Dec 2015 AP01 Appointment of Shou-Bai Chao as a director on 1 December 2015
07 Dec 2015 AP01 Appointment of Dr Michael Craig Diem as a director on 1 December 2015
04 Dec 2015 AP03 Appointment of Mr Matthew Ian Conacher as a secretary on 1 December 2015